Novel copper-cysteamine and methods of use
US-2018339047-A1 · Nov 29, 2018 · US
US11865194B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11865194-B2 |
| Application number | US-202318297575-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 7, 2023 |
| Priority date | Oct 13, 2020 |
| Publication date | Jan 9, 2024 |
| Grant date | Jan 9, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein is a benzene ring-containing glucose derivative of formula (I): where R 1 is each independently and R 2 is hydrogen. This application also provides a radioactive drug, including a complex formed by the benzene ring-containing glucose derivative and a radionuclide. Use of the benzene ring-containing glucose derivative in the tumor treatment and diagnosis is further provided.
Opening claim text (preview).
What is claimed is: 1. A benzene ring-containing glucose derivative of formula (I): wherein one or two R 1 are located on a benzene ring in formula (I); the one or two R 1 are each independently when there is one R 1 , R 1 is on 3-position or 4-position of the benzene ring in formula (I); when there are two R 1 , the two R 1 are on 3-position and 4-position of the benzene ring, respectively; R 3 is hydrogen; m is 0 or 1; and represents chemical bonding between R 1 and the benzene ring in formula (I); R 2 is hydrogen; n is 0, 1 or 2; and when m=0 and n=1, R 1 is not on the 4-position of the benzene ring. 2. The benzene ring-containing glucose derivative of claim 1 , wherein the sum of m and n is 2. 3. The benzene ring-containing glucose derivative of claim 1 , wherein there is one R 1 , and the one R 1 is on the 3-position of the benzene ring. 4. A radioactive drug, comprising: a complex formed by a benzene ring-containing glucose derivative and a radionuclide; wherein: the radionuclide is 99m Tc; the benzene ring-containing glucose derivative is represented by formula (I): and the complex is represented by formula (II): wherein in formula (I) and formula (II): one or two R 1 are located on each of benzene rings; the one or two R 1 are each independently wherein when there is one R 1 , R 1 is on 3-position or 4-position of each of the benzene rings; when there are two R 1 , the two R 1 are on 3-position and 4-position of each of the benzene rings, respectively; R 3 is hydrogen: m is 0 or 1; and represents chemical bonding between R 1 and each of the benzene rings; R 2 is hydrogen; n is 0, 1 or 2; and when m=0 and n=1, R 1 is not on the 4-position of each of the benzene rings. 5. A tumor imaging method, comprising: administering the radioactive drug of claim 4 to a subject in need thereof; and performing imaging of the subject by single photon emission computed tomography (SPECT).
inorganic Tc complexes or compounds · CPC title
having the esterifying carboxyl radicals directly attached to carbocyclic rings · CPC title
Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers · CPC title
Aminosugars · CPC title
Processes for the preparation of sugar derivatives · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.